From: CD40 polymorphisms were associated with HCV infection susceptibility among Chinese population
SNPs (genotype) | Group A | Group B | Group C | Group (B + C)/Group A | Group C/Group B | ||
---|---|---|---|---|---|---|---|
n(%) | n(%) | n(%) | OR(95%CI)a | P a | OR(95%CI)b | P b | |
rs1535045 | |||||||
 CC | 688 (46.5) | 214 (43.9) | 328 (43.6) | 1.00 | – | 1.00 | – |
 CT | 648 (43.8) | 211 (43.3) | 322 (42.8) | 1.043 (0.884-1.231) | 0.618 | 0.979 (0.763-1.256) | 0.867 |
 TT | 142 (9.7) | 62 (12.8) | 103 (13.6) | 1.397 (1.078-1.809) | 0.011 | 1.095 (0.760-1.576) | 0.626 |
Dominant model | Â | Â | Â | 1.109 (0.948-1.297) | 0.197 | 1.005 (0.796-1.271) | 0.964 |
Additive model | Â | Â | Â | 1.135 (1.011-1.275) | 0.032 | 1.027 (0.869-1.215) | 0.752 |
Recessive model | Â | Â | Â | 1.368 (1.070-1.749) | 0.012 | 1.106 (0.785-1.559) | 0.564 |
rs1883832 | |||||||
 CC | 567 (39.4) | 178 (37.3) | 275 (37.7) | 1.00 | – | 1.00 | – |
 CT | 693 (48.2) | 217 (45.5) | 333 (45.6) | 1.019 (0.858-1.210) | 0.833 | 1.008 (0.778-1.306) | 0.951 |
 TT | 178 (12.4) | 82 (17.2) | 122 (16.7) | 1.351 (1.060-1.722) | 0.015 | 0.980 (0.695-1.383) | 0.909 |
Dominant model | Â | Â | Â | 1.090 (0.926-1.282) | 0.300 | 1.001 (0.785-1.275) | 0.997 |
Additive model | Â | Â | Â | 1.127 (1.004-1.263) | 0.042 | 0.993 (0.841-1.173) | 0.937 |
Recessive model | Â | Â | Â | 1.337 (1.069-1.673) | 0.011 | 0.976 (0.713-1.335) | 0.878 |
rs4810485 | |||||||
 GG | 604 (40.6) | 190 (39.7) | 306 (41.0) | 1.00 | – | 1.00 | – |
 GT | 693 (46.6) | 211 (44.1) | 328 (43.9) | 0.970 (0.819-1.148) | 0.721 | 0.981 (0.761-1.266) | 0.885 |
 TT | 191 (12.8) | 78 (16.2) | 113 (15.1) | 1.201 (0.944-1.527) | 0.136 | 0.927 (0.655-1.312) | 0.667 |
Dominant model | Â | Â | Â | 1.021 (0.871-1.196) | 0.802 | 0.967 (0.762-1.227) | 0.780 |
Additive model | Â | Â | Â | 1.063 (0.949-1.190) | 0.290 | 0.967 (0.819-1.141) | 0.688 |
Recessive model | Â | Â | Â | 1.220 (0.976-1.526) | 0.081 | 0.936 (0.679-1.290) | 0.685 |